---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-25-000083"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:13:42.069680+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Regenerex Pharma enters licensing deal with Holista for ovine collagen wound care

## Summary
- Exclusive rights to use Holista's ovine collagen in wound care and distribution in USA.
- Ovine nano-collagen integrated into Regenerex's QBx™ technology to accelerate deep tissue regeneration.
- Collagen sourced from ethically raised, disease-free Australian sheep; avoids mad cow disease concerns.
- CEO Greg Pilant says ovine collagen is safer and more culturally acceptable than bovine/porcine sources.
- Agreement targets advanced wound care solutions for U.S. and international markets.

## SEC filing metadata
- accession: 0001472375-25-000083
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/0001472375-25-000083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-25-000083
- JSON: https://secwatch.observer/filing/0001472375-25-000083.json
- Plain text: https://secwatch.observer/filing/0001472375-25-000083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.